Surveillance of Fungal Infections During Construction Activity

Aspergillosis Clinical Trial

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT00473252
• Other study ID #: BE003
• Status: Completed
• Phase: N/A
• First received: May 14, 2007
• Last updated: May 19, 2011
• Start date: May 2006
• Est. completion date: July 2009

Study information

• Verified date: May 2011
• Source: University Hospital Inselspital, Berne
• Contact: n/a
• Is FDA regulated: No
• Health authority: Switzerland: Ethikkommission
• Study type: Observational

Clinical Trial Summary

Fungal infections in immunocompromised patients occuring during construction activities in hospitals have repeatedly been reported.

However, the question of a causal relation between construction activities and infections has never been addressed systematically and prospectively.

To answer this question, we will monitor our immunosuppressed patients' health status, as well as fine dust and aspergillus spore contents in the air during a three year construction activity period in our hospital.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 340
• Est. completion date: July 2009
• Est. primary completion date: July 2009
• Accepts healthy volunteers: No
• Gender: Both
• Age group: 16 Years and older

Eligibility

Inclusion Criteria:

• Kidney transplantation

• Chronic hemodialysis treatment

Study Design

Observational Model: Cohort, Time Perspective: Prospective

Related Conditions & MeSH terms

• Aspergillosis

Locations

Country	Name	City	State
Switzerland	Dept. Nephrology & Hypertension, Univ. Hospital Bern	Bern

Sponsors (1)

Lead Sponsor	Collaborator
University Hospital Inselspital, Berne

Country where clinical trial is conducted

Switzerland,